Since overexpression of SET and CIP2A induces cancer progression, and knockdown of SET and CIP2A inhibits tumor growth, the effects of anticancer drugs might be different in between cancer cells with SET and CIP2A and those with their knockdown. Here, SET is linked to neoplasm.